- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lexaria Bioscience Corp (LEXX)
The Lexaria Bioscience share price today is 5.221, view NASDAQ LEXX stock exchange data. Track the latest Lexaria Bioscience share price with real-time updates on LEXX stock performance including market cap, day range, 52-week range and dividend yield. Access LEXX charts, earnings dates and analyst estimates to support your investment decisions.
5.850
-0.015(-0.26%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.920
5.900
52 wk Range
0.350
6.392
LEXX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.9205.900
52 wk Range
0.3506.392
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LEXX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
52.500
Upside
+797.44%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 52.500
(+797.44% Upside)
Earnings
Latest Release
17-07-2026
EPS / Forecast
-1.20 / -0.06
Revenue / Forecast
-- / --
Compare LEXX to Peers and Sector
Metrics to compare | LEXX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLEXXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −0.6x | −0.4x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 2.0x | 1.0x | 2.6x | |
Price / LTM Sales | 50.0x | 1.3x | 3.0x | |
Upside (Analyst Target) | - | 61.5% | 56.0% | |
Fair Value Upside | Unlock | 12.8% | 9.1% | Unlock |
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company’s DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Lexaria Bioscience (LEXX) Share Price Today?
The Lexaria Bioscience share price today is 5.850.
What is the current Lexaria Bioscience (LEXX) share price and day range?
As of 03-08-2026, the Lexaria Bioscience share price is 5.850, with a previous close of 0.391. The share price has ranged from 4.920 to 5.900 today, while the 52-week range spans from 0.350 to 6.392.
What Is the Lexaria Bioscience Market Cap?
As of today, Lexaria Bioscience market cap is 9.670M.
What Is the Lexaria Bioscience (LEXX) Share Price Target?
The average 12-month share price target for Lexaria Bioscience is 52.500, with a high estimate of 82.49996 and a low estimate of 22.49999. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +797.44% Upside potential.
What Is Lexaria Bioscience's Earnings Per Share (TTM)?
The Lexaria Bioscience EPS (TTM) is -5.140.
When Is the Next Lexaria Bioscience Earnings Date?
Lexaria Bioscience will release its next earnings report on 28-10-2026.
From a Technical Analysis Perspective, Is LEXX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Lexaria Bioscience Trade On?
Lexaria Bioscience is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Lexaria Bioscience?
The stock symbol for Lexaria Bioscience is "LEXX."
How Many Times Has Lexaria Bioscience Stock Split?
Lexaria Bioscience has split 4 times.
How Many Employees Does Lexaria Bioscience Have?
Lexaria Bioscience has 7 employees.
What Is the LEXX After Hours Price?
LEXX's last after hours stock price is 0.420, the stock has changed by 0.029, or 7.420%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.